1. Home
  2. SMID vs COYA Comparison

SMID vs COYA Comparison

Compare SMID & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

HOLD

Current Price

$21.95

Market Cap

117.7M

Sector

Industrials

ML Signal

HOLD

Logo Coya Therapeutics Inc.

COYA

Coya Therapeutics Inc.

SELL

Current Price

$4.85

Market Cap

102.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SMID
COYA
Founded
1960
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.7M
102.7M
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
SMID
COYA
Price
$21.95
$4.85
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $15.21
AVG Volume (30 Days)
9.5K
★ 145.8K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 62.76
N/A
EPS
★ 0.51
N/A
Revenue
★ $93,446,000.00
$7,945,753.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$387.14
P/E Ratio
$44.63
★ N/A
Revenue Growth
19.03
★ 123.57
52 Week Low
$22.25
$3.71
52 Week High
$42.15
$7.75

Technical Indicators

Market Signals
Indicator
SMID
COYA
Relative Strength Index (RSI) 25.52 49.82
Support Level N/A $4.42
Resistance Level $31.47 $5.17
Average True Range (ATR) 0.76 0.26
MACD -0.10 -0.01
Stochastic Oscillator 0.31 41.57

Price Performance

Historical Comparison
SMID
COYA

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Share on Social Networks: